2 patients discharged in 12 hours after new antibody therapy in India
Two Covid patients released in 12 hours after undergoing monoclonal antibody therapy
Ganga Ram Hospital, located in New Delhi, reports that after using Monoclonal antibody therapy, two Covid positive patients have shown fast successful results within the first week. Both of the patients recovered and were discharged in 12 hours.
One of the patients, a healthcare worker, had been admitted due to high fever, cough, extreme weakness, myalgia, and leukopenia. In a press release, the hospital stated that they had administered REGCov2 (CASIRIVIMAB Plus IMDEVIMAB) on the sixth day of the disease.
"Patient's parameter improved within 12 hours and was discharged," the release stated.
The second case was of the 80-year-old R K Razdan who was diabetic, hypertensive, and had high-grade fever and cough.
According to the release, Razdan's oxygen saturation was more than 95 percent on room air. Monoclonal antibody and a CT scan confirmed mild disease.
"He was given REGCov2 on Day 5 of disease. Patient's parameter improved within next 12 hours," the release added.
Dr Pooja Khosla, a senior consultant of the Department of Medicine at Sir Ganga Ram Hospital said, "Monoclonal antibody could prove to be a game-changer in times to come if used at an appropriate time. It can avoid hospitalisation in high-risk groups and progression to severe disease. It can help escape or reduce the usage of steroids and immunomodulation which would further reduce the risk of fatal infections like Mucormycosis, secondary bacterial and viral infections like CMV."
"The awareness about early identification of high-risk categories in our population and timely therapy with Monoclonal antibody as daycare treatment may reduce the burden of cost on the healthcare sector," she added.
